PAR 5.81% 20.3¢ paradigm biopharmaceuticals limited..

Sharewise Presentation 22/7/24, page-60

  1. 6,546 Posts.
    lightbulb Created with Sketch. 1971
    I think PR should actually vacate both the chair and CEO role. I have little doubt PR was a big reason why PAR lost its last CEO so quickly.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.